Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
about
Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitisReview article: acute severe ulcerative colitis - evidence-based consensus statements.A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research.The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].Recent trends in diagnostic techniques for inflammatory bowel diseaseDiagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic ScoreEvaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels.European evidence based consensus for endoscopy in inflammatory bowel disease.The role of mucosal healing in the treatment of patients with inflammatory bowel diseaseEndoscopic scoring systems for inflammatory bowel disease: pros and cons.Colonoscopic evaluation in ulcerative colitis."Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings.The role of capsule endoscopy in assessing mucosal inflammation in ulcerative colitis.Predicting outcomes in acute severe ulcerative colitis.Conventional drug therapy for inflammatory bowel disease.Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.Improving the utility of colonoscopy: Recent advances in practice.A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis.Elaboration and validation of Crohn's disease anoperineal lesions consensual definitions.Endoscopic Disease Activity in Inflammatory Bowel Disease.Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis.Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.A comparison of approaches for adjudicating outcomes in clinical trials.Polyp morphology: an interobserver evaluation for the Paris classification among international experts.Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study.Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
P2860
Q28072104-FEBEE684-F40B-4321-B3C4-E3E505271F81Q31140142-924FB7DC-0199-43A6-AECE-A46D57C61290Q33607108-4EBD152E-A76D-45BF-8740-98333EBB89E9Q33696416-98452FA5-D532-42DB-8D15-1A9DF52352F1Q34528270-BA5D45C0-8B20-4072-AF13-E2AAD0E9A5D7Q35169255-545691A7-5DA0-450F-AC0B-C603A61FD453Q35625694-1C06ECC8-0309-4318-8BA0-26E74C5CF610Q35626222-F3255EE4-F39C-4BA5-9775-41EF5C4AFF60Q37095800-68C79B57-FFBF-4288-BB94-A0245753A70DQ37118462-370FF04D-0168-4603-919E-926924458AD5Q37616248-CEA71C03-3308-4302-9DBA-8B41C5C0A256Q38159096-23F406AA-B8DB-4B8C-A66D-F8B8E16309C6Q38176299-6E543746-9294-43B3-82EE-3E9AF68535D2Q38197726-3A113003-C414-4208-9F8D-D5C602B7006AQ38216220-8F454A6B-BD73-4533-A1E7-614AE9311EF1Q38217234-E6DBCE0B-ED64-49A1-A6ED-E0FD96A486CBQ38219796-0E1CB0C7-DC36-4163-901C-96C25EED8858Q38223324-4574C789-54AA-4C0F-AD23-6997C6890C02Q38286166-7E184DCD-C964-4452-AD03-69A92064374CQ38293796-C3B8FEE3-7477-4A4A-87A8-6B74B9488D9DQ38331566-B4E69417-B8CD-4361-A963-3AA63B680BD6Q38474301-F4D842B4-7C75-4410-98E6-FABF3ACA0E4EQ38531008-D0288C1C-0BD2-490B-B253-935C896783DBQ38554542-ED773481-7A18-494C-A605-88F407323618Q38589686-4C94B675-1620-4E53-B0C3-AB8FE576F3E4Q38609300-A33D7F53-7D60-401B-AF84-0BC1F94270B7Q38664077-180E3415-2FDA-4F5A-AB20-65C76D04AAD1Q38694153-02388576-8D0C-460D-9ECE-1695B914FE76Q38768496-AFF4ACE2-5588-44C9-BE7A-5E4C28F590B7Q38775457-3C86CDB8-64B7-40F7-A722-01326264F84CQ38797791-C53EDA25-BCD4-4DAF-BD85-8C8862821682Q38906748-4CE4FCD7-4766-4412-8394-FAC6BB05B78CQ39064412-54AF882D-FC84-41C2-ACEC-780059506404Q39098635-5EBC9A32-6177-40F6-A10E-1685A4809396Q39360120-84A8A713-B9CD-4BCC-8A50-09EAD3C39F56Q40230218-D9D5436B-3023-4985-8067-B49DF77BFAB4Q40811180-A9284E07-D019-433B-8288-71AB009E7968Q40926333-EF9ACA32-5533-4596-95CC-FD7FC47CB70AQ42280471-CECD676D-B854-4467-894F-D6EA413CEFB6Q42375565-A017F9C9-EA78-4C66-AD3D-AAC54BB9CED2
P2860
Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Reliability and initial valida ...... endoscopic index of severity.
@ast
Reliability and initial valida ...... endoscopic index of severity.
@en
Reliability and initial valida ...... endoscopic index of severity.
@nl
type
label
Reliability and initial valida ...... endoscopic index of severity.
@ast
Reliability and initial valida ...... endoscopic index of severity.
@en
Reliability and initial valida ...... endoscopic index of severity.
@nl
prefLabel
Reliability and initial valida ...... endoscopic index of severity.
@ast
Reliability and initial valida ...... endoscopic index of severity.
@en
Reliability and initial valida ...... endoscopic index of severity.
@nl
P2093
P50
P1433
P1476
Reliability and initial valida ...... endoscopic index of severity.
@en
P2093
Bruce E Sands
Bruce R Yacyshyn
Christian A Bernhardt
Dan Schnell
Gary R Lichtenstein
Jean-Yves Mary
Maria T Abreu
Patrick Schnell
Philippe R Marteau
Piotr Krzeski
P304
P356
10.1053/J.GASTRO.2013.07.024
P407
P577
2013-07-25T00:00:00Z